ABDSEROTEC search AbDSerotec IL6 products
includes other brands or spellings
|
| ic | | Serotec rabbit polyclonal anti-IL-6 antibody was used in immunocytochemistry to study interleukin-6 expression in HP75 human pituitary tumor cells. |
R & D SYSTEMS search R & D Systems IL6 products
includes other brands or spellings
|
| block | | R&D Systems anti-human IL-6 was was used in blocking experiments to neutralize IL-6 in human renal carcinoma ACHN cells. |
| block | | R&D Systems anti-hIL-6 antibody was used in human cells and in blocking expriments to study the role of KSHV in the activation of STAT3 or the role of STAT3 in KS tumors. |
| elisa, ih | | R&D Systems IL-6 ELISA kit and R&D Systems mouse monoclonal anti-human IL-6 (clone 6708.111) antibody was used in ELISA and immunohistochemistry to study interleukin-6 level in giant-cell arteritis patients. |
| elisa | | R&D Systems IL-6 antibody was used to study airway smooth muscle function modulation. |
| elisa | | R&D Systems IL-6 Duoset kit was used in ELISA to study TLR3 expressin in human endometrial epithelial cells. |
| elisa | | R&D Systems anti-IL-6 antibody in ELISA kit was used in ELISA to study the role of Interleukin-17 in stimulating the release of IL-8, Gro, and G-CSF from the airway epithelium. |
| elisa | | R&D IL-6 ELISA kit was used to study interleukin-6 system regulation in stroke. |
| elisa | | R&D System anti-IL-6 antibody (which was in ELISA kits) was used in human RCC cell lines and in ELISA to study the relationship between increased activation of CCAAT/enhancer binding protein-ß and the invasiveness of renal cell carcinoma. |
| elisa | | R & D Systems anti-IL-6 antibody (which was in ELISA kit) was used in human SSc ibroblast and in ELISA to study the effect of intracellular IL-1α-binding proteins on biological functions of endogenous IL-1α in systemic sclerosis fibroblasts. |
| elisa | | R&D Systems IL-6 ELISA kit was used to study capsaicinoids' effect on epithelial cell death. |
| ih, wb | | R & D Systems goat polyclonal human IL-6 antibody was used in western blot and immunohistochemistry to study cyclooxygenase-2, interleukin-1beta, interleukin-6, and NF-kappaB expression in human colorectal cancer. |
| ih | | R&D Systems goat polyclonal anti-human IL-6 antibody was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role for IL-6 in driving Stat3 activation in breast cancer. |
BD BIOSCIENCES search BD Biosciences IL6 products
includes other brands or spellings
|
| elisa | | Pharmingen anti-IL-6 antibody (which was in ELISA OptEIA antibody pair kits) was used in venous blood from human and in ELISA to study the cytokine production in CMC patients. |
| elisa | | Pharmingen human IL-6 ELISA kit was used to study candidate toll-like receptor 9 agonists. |
| ih, wb | | Pharmingen rat anti-human IL-6 antibody (clone MQ2-6A3) was used in western blot and immunohistochemistry to study CD99 and CD106 (VCAM-1) expression in human testis. |
INVITROGEN search Invitrogen IL6 products
includes other brands or spellings
|
| elisa | | BIOSOURCE IL-6 enzyme-linked immunosorbent assay kit was used to study the Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2). |
| elisa | | Biosource anti-IL-6 antibody (which was in ELISA kit) was used in human corneal epithelial cells (HCEs) and primary human corneal fibroblasts (HCRFs) and in ELISA to study the role of viral DNA and immune complexes in the release of IL-6 by corneal cells. |
| elisa | | BioSource Europe SA anti-IL-6 antibody (which was in ELISA kit) was used in venous blood samples from human and in ELISA to study the association of serum levels of some proinflammatory cytokines in vivo and their correlation with severity of psoriasis. |
BENDER SYSTEMS
|
| elisa | | Bender Systems IL-6 ELISA ket was used to study inflammatory response induced by glucan. |
CELL SCIENCES
|
| block, elisa | | Cell Sciences anti-IL-6 antibody (which was in ELISA kit) and anti-IL-6-blocking antibody 522 were used in human breast cancer cells, and which respectively used in ELISA and blocking expriments to study the role for IL-6 in driving Stat3 activation in breast cancer. |
IDS
|
| elisa | | IDS IL-6 Eli-Pair antibody kit was used to study interleukin-6 expression in HP75 human pituitary tumor cells. |
Articles Reviewed |
| 1. Carol E Jones et al. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. 2002 |
| 2. E Veräjäkorva et al. CD 99 and CD 106 (VCAM-1) in human testis. 2002 |
| 3. Mototsugu Oya et al. Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. 2003 |
| 4. Christopher A Reilly et al. Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. 2003 |
| 5. Christian Maihöfner et al. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. 2003 |
| 6. José Hernández-RodrÃguez et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. 2003 |
| 7. Daniela Acalovschi et al. Multiple levels of regulation of the interleukin-6 system in stroke. 2003 |
| 8. Desa Lilic et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. 2003 |
| 9. Omar Tliba et al. Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. 2003 |
| 10. S A Borg et al. Expression of interleukin-6 and its effects on growth of HP75 human pituitary tumor cells. 2003 |
| 11. Andreas Till et al. The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression. 2005 |
| 12. Ekambar R Kandimalla et al. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. 2005 |
| 13. Rebecca L Jorgenson et al. Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA. 2005 |
| 14. Ozer Arican et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. 2005 |
| 15. Seiji Ueno et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. 2006 |
| 16. Juergen Luhm et al. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio. 2006 |
| 17. Kozaburo Hayashi et al. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. 2006 |
| 18. Yasushi Kawaguchi et al. Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts. 2006 |
| 19. Almira S Punjabi et al. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. 2007 |
| 20. Marjan Berishaj et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. 2007 |